Scientific interest in saliva as a diagnostic matrix has greatly increased over the last decade. The Triage" screening test (Biosite Diagnostics), a rapid immunological test used to detect recreational drugs in the urine, was used to compare two biological matrixes: a non-conventional one, saliva, and a traditional one, urine. Twenty-one drug abusers collected one urine and one saliva specimen, both of which were tested with the Triage kit. Data were validated by gas-chromatography-massspectrometry (GC-MS). Results were positive for methadone in 9 saliva and 14 urine specimens, for opiates in 2 and 10, respectively, and for barbiturates in 2 specimens. Saliva specimens were negative for cannabis, THC, benzodiazepines and tricyclic antidepressants, although the GC-MS analysis revealed low concentrations of these drugs in the saliva. The study demonstrates the possibility of using saliva as a diagnostic matrix to test for drug-taking; however, the Triage kit must be improved before being used with saliva.
Scientific interest in saliva as a diagnostic matrix has greatly increased over the last decade, and a number of clinical studies have indicated that it can be used to confirm diagnosis of systemic diseases such as cystic fibrosis, celiac disease and Sjogren's syndrome (I), and to determine tumour markers such as p53 (2) , c-erb B-2, CA 15-3 (3), CA 125 (4), as well as a variety of biological agents including Shigella, Taenia solium and Helicobacter pylori and also viruses such as Herpes virus 8, the Epstein Barr virus, hepatitis and HIV (5) (6) (7) . Saliva monitoring would also be ideal to test endocrine functions, since a number of samples are required over a short interval of time. Several studies have demonstrated the possibility of evaluating the presence of psychiatric (8) , immunosupressor (9) , antitumour (l0), or recreational drugs such as opiates, in the saliva.
Morphine remains in the saliva for only a short time and its concentration is about 10% of that in the urine (11) . The concentration of heroin in the saliva is lower than that in the plasma after intravenous injection, whereas it is higher for 2-3 hours after smoking or sniffing the drug. Among synthetic opiates, the presence in the saliva of methadone, important for its therapeutic functions, has shown good correlation with plasma concentration (12) . Variousstudies have indicated that cocaine is excreted rapidly via the saliva after sniffing, the concentration generally being higher than that in the plasma (13) . Amphetamine and 3,4-methamphetamine are three times higher in the saliva than in the plasma (14) .
In the tranquilliser category, Diazepam is surely the most widely abused drug, and its saliva concentration differs greatly from the blood concentration, leaving application of this methodology uncertain (15) . Among barbituric acid derivatives such as amobarbital, secobarbital and hexobarbital, saliva concentrations range from 30 to 40% of plasma concentrations, while for phenobarbital they are around 10% (16) . Of the hallucinogens, phencyclidine concentration is higher in the saliva than in the plasma, the ratio being 1.5-3 times (17); marijuana and hashish have been found in high concentrations, both in the plasma (14.4%) and in saliva (9%);however, permanence is longer in the urine (18) .
The study aimed to evaluate the Triage screening test, comparing results on two biological matrixes: a nonconventional one, saliva, and a traditional one, urine.
MATERIALS AND METHODS

Subjects and biological matrixes
Twenty-one volunteer participants were included in the study; all were from the Substance Abuse Department at the Pharmacological Hospital, Ancona (age range 26-44; 17 m, 4 f) ( Table I ). The use of human specimens conformed to an informed-consent protocol reviewed and approved by the appropriate Institutional Review Board. The participants were asked to provide a urine specimen in a test tube after having ingested a dose of liquid methadone; they were then asked to spit into a container of the type used for urine culture, until the quantity of saliva reached an approximate amount of 1-1.5 m!. No stimulation of any kind was used to elicit the spitting action.
Saliva and urine specimens were also collected from 5 subjects who had not taken narcotic substances and who were part ofa drug-free control group. Aliquots ofthese specimens were fortified with different amounts of methadone, opiates or cocaine, to produce a series with concentrations up to 300ng/ml; THC was added likewise, up to 50ng/m!. Test tubes and containers were stored at -20°C until analysis.
Immunoenzymatic screening
The biological fluids were examined using the Triage kit (Biosite Diagnostics Incorporated, San Diego, CA, U.S.A.), a rapid immunological test used for qualitative analysis and detection of the principle metabolites for eight classes of recreational drugs in the urine (Table 11 ). The test was developed to an immunological-chemical patent "ASCEND tm Multlmmunoassay". The analytical device contains a reaction panel, a testing platform and a washing solution. The reaction panel comprises: a) mouse monoclonal antibodies specific for the principal drug metabolites, Iyophilised in a protein synthesis matrix containing < 0.01% of sodium azide (white spherule) b) derivatives of drugs conjugated with particles of gold colloidal, lyophilised in a protein synthesis matrix containing < 0.01% of sodium azide (purple spherule) c) Tris/Tris x HCI Iyophilised buffer of 200 mmol/I (yellow spherule).
The reaction panel antibodies are immobilised on the reaction platform membrane; the washing solution consists of boric acid, sodium chloride, sodium azide and a stabiliser.
The specimens are consecutively thawed and brought to room temperature. With urine specimens, the procedure indicated by the manufacturer was followed. In the case of saliva, since the viscous fluid contained solid materials, the specimens were centrifuged for l Omin at 3000 rpm; 1.5 mL were then taken and placed in another test tube (the remainder being returned to the freezer for subsequent analyses). After placing the container in the oven at 80°C, the saliva is dried to full evaporation (approximately three days). This strategy was decided after looking at prior trials without evaporation in which the test results were always negative. However, it was also decided to lower the cut-off limit and concentrate primarily on the molecule of the drug in question; 0.14 ml distilled water was then added to the dried saliva. The lower cut-off point was checked empirically using control specimens containing known quantities of drug.
The subsequent analytical procedure was identical for both fluids, as follows: the testing platform area is opened and 0.14 ml of biological fluid are transferred into the interior, using a special tip on a pipette. Incubate for 10m between 15°C and 25°C. Discard the tip after use; apply a new tip to the pipette and transfer the reaction mixture from the testing platform to this tip and hence onto the membrane in the reaction area. Wait until complete absorption; put three drops of the washing solution in the centre of the testing platform and wait until complete absorption. Evaluate the analysis and read the result within 5' .
Gas chromatography -Mass Spectrometry
The analysis was validated by means of gaschromatography-mass-spectrometry (GC-MS). The device used was the "Saturn 4D" produced by Varian. With cocaine, opiates and cannabis the procedure was as follows (19): Initial sample preparation: the glass test tube was washed, decontaminated and silanized beforehand. 200J.!L of saliva sample were injected into the test tube for examination, after 200J.!L of internal standard (scopolamine) was added, together with 1 ml of an acetate buffer with pH 4. The whole was stirred manually to guarantee homogeneity ofthe mixture and the test tube was positioned in an automatic sampler SPE (solid extraction phase): the extraction pump (Bond Elut Certify) was activated with 2 ml ofmethanol and acetate buffer, pH 4. The saliva sample was placed in the pump with water and acetone nitrile, so as to create a vacuum-sealed state for 5' at 15 psi. The drug was now eluted from the pump, with 0.75 ml of dichloride methane/ isopropanol/ ammonia at 80:20:2 (v/v). 3.9 ml of 0.1 N hydrochloric acid were added to remove the electrolytes. The dry sample was then fortified with 2.5 ml methanol, followed by a further drying process for 1.5 min employing benzoyl ecgonina plus dichloride methane/ isopropanol/ ammonia at 80:20:2 (v/v) Evaporation and concentration ofthe eluate: the extract is evaporated until dry under a light flow ofnitrogen at 90°C for 6' Derivation: 0.075ml of N,O-bis trifluorine acetamide (BSTFA) is added. The sample is mixed for 0.3' and reheated at 80°C for 20'. Anhydride pentafluorine propionic and pentafluorine-l-propanol may alternatively be employed at 100°C for 50'.
RESULTS
The results of the qualitative analysis using the Triage test are illustrated in Table I .
It must be clarified that, for the 21 participants, the saliva samples totalled 23 and the urine samples 20. For the saliva alone, two samples were intentionally collected for patients "D" and "S", at intervals of approximately 30' (during which time methadone was taken) to establish whether there would be any difference. With regard to the urine, no specimen was obtained for patient "R", who was undergoing a withdrawal crisis and thus in difficulty.
Some interesting data emerged with regard to methadone, comparing the saliva with the urine results (Table I) . Methadone was only given to 15 patients, because the others had ended their substitution therapy; it was detected in the saliva with an average accuracy of 69.23%. Such a positive result, higher than those for other drugs, could depend on the recent ingestion, half an hour prior to obtaining the samples; this is particularly evident in subject "S" (Table I) .
The urine analysis confirmed the accuracy and sensitivity of the Triage test, as reported in a recent study that compared this kit with "Signify ER" from Applied Biotech (20) . Statements by the subjects were not considered valid in regard to effective drug use. Since the Triage test has a sensitivity level of 99.3% and an accuracy of 99.6% (20) , the urine test was employed for this purpose, assuming its reliability to be 100%.
Heroin, which was taken by 10 subjects, was only detected in the saliva of 2 (20%) of them (Table I) .
Interesting data were obtained for patient "0", who injected the drug 3 h before the specimen was taken. Concentrations in the saliva were undoubtedly higher in the first few hours after injection, and could thus be detected and calculated with the kit. Successively, when the drug level decreased, the test was unable to reveal it. This hypothesis is validated by the data relating to subject "R", who was under the influence of the drug at the time of sampling. The same finding was reported in a study conducted by the Addiction Research Center (ARC) at the Baltimore National Institute on Drug Abuse (21) .
The Triage test ascertained the presence of cocaine and marijuana in the urine samples of 3 subjects, but the same outcome was not obtained from the saliva; this might depend on the fact that the drug was taken some time before testing. In the case of benzodiazepines and tricyclic antidepressants, there was no correlation found between results for the two biological matrixes. On the contrary, for barbiturates, only taken by two subjects, "T" and "U", the correspondence was perfect, which is a positive result in that it attests to the validity of the kit for qualitative drug analysis in the saliva, including when the drug is taken some time before the test.
Unlike the corresponding urine samples, six saliva samples were negative for opiates at the Triage test, two were negative for cocaine and one for THC. On the contrary, gas chromatography confirmed the presence of these drugs at low concentrations. Chromatograms of subjects H (Fig. 1) and S (Fig. 2) clearly show the presence of opiates and of cocaine, together with the quantities.
DISCUSSION
To date, only one study has used the Triage test kit to compare serum with urine (22) , no studies are reported on other biological fluids. It was therefore our intent to explore the validity of the Triage Test when used on saliva. Drug testing on saliva offers several advantages: firstly it is a non-invasive method. The saliva may be collected without requiring the subject to spit into a test tube, employing different and more acceptable methods. Furthermore, urine analysis compromises privacy, since a urine sample must be taken under close supervision by a competent medical professional who ensures that sample falsification is not possible.Otherwise,falsification or altered urine samples is easily accomplished. Opportunities for falsification are greatly reduced with saliva testing. Moreover,in terms of medicalstaffsafety, blood samplestaken by the parenteral route entail a real risk of contamination and also of infection of the medical personnel. This is not the case with saliva because, if a virus is present, its concentration is lower than in the blood. Notwithstanding these advantages, the results of tests available on today's market do not satisfy all requirements, and the study examined the possibility of improving sensitivity of the analytical tool by lowering the cut-off levels, although unfortunately this was not always sufficient.
There is no doubt that, with today's methods, saliva or blood may be utilised to evaluate acute drug intoxication. The urine is also valid for diagnostic detection when drug ingestion has taken place a significant time before a test can be administered. From this standpoint, the efficiency of examining the saliva for drug detection should be considered when immediate determination is necessary, as is the case at police checkpoints and in hospital emergency rooms. However, the Triage test kit should be modified structurally in order to improve its reliability.
